Researchers at the Jacksonville Center for Clinical Research announced that they are starting a new clinical trial for people who can’t receive the COVID vaccine because of a weakened immune system.
Instead of using Monoclonal antibodies to treat a person infected with COVID, this new antibody would be injected to prevent a COVID infection. And it would be COVID-specific.
That’s because they are medically not able to receive the COVID vaccine due to a weakened immune system. But that could soon change. Researchers at the Jacksonville Center for Clinical Research are starting a clinical trial for high-risk people who are unable to receive any of the COVID vaccines. This also includes certain people with diabetes. Koren said the solution is not a new vaccine for high-risk people but rather antibodies.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Long COVID: Cedars-Sinai Researchers Find COVID-19 Vaccine Produces Antibodies Far Longer Than ExpectedFindings show people with long COVID-19 respond differently to COVID-19 vaccines. A new study by investigators from the Smidt Heart Institute at Cedars-Sinai suggests long COVID-19 might be caused by a dysfunction of the immune system. The study, published in the journal BMC Infectious Disease
続きを読む »
Benson Visitor Center becomes the first certified Autism Center in Cochise CountyEarlier this month the Benson Visitor Center became the first certified Autism Center in Cochise County. Three staff members completed the online training to earn the designation.
続きを読む »
Looking back at the Blue Angels’ historyThe Blue Angels celebrated its 77th birthday on Monday. To celebrate, we wanted to share some “blue” history. 🎂✈
続きを読む »